Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M705869200 on July 30, 2007

J. Biol. Chem., Vol. 282, Issue 39, 28549-28556, September 28, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/39/28549    most recent
M705869200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawamata, Y.
Right arrow Articles by Olefsky, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawamata, Y.
Right arrow Articles by Olefsky, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tumor Necrosis Factor Receptor-1 Can Function through a G{alpha}q/11-beta-Arrestin-1 Signaling Complex*

Yuji Kawamata1, Takeshi Imamura1, Jennie L. Babendure, Juu-Chin Lu, Takeshi Yoshizaki, and Jerrold M. Olefsky2

From the Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego, La Jolla, California 92093-0673

Tumor necrosis factor-{alpha} (TNF{alpha}) is a proinflammatory cytokine secreted from macrophages and adipocytes. It is well known that chronic TNF{alpha} exposure can lead to insulin resistance both in vitro and in vivo and that elevated blood levels of TNF{alpha} are observed in obese and/or diabetic individuals. TNF{alpha} has many acute biologic effects, mediated by a complex intracellular signaling pathway. In these studies we have identified new G-protein signaling components to this pathway in 3T3-L1 adipocytes. We found that beta-arrestin-1 is associated with TRAF2 (TNF receptor-associated factor 2), an adaptor protein of TNF receptors, and that TNF{alpha} acutely stimulates tyrosine phosphorylation of G{alpha}q/11 with an increase in G{alpha}q/11 activity. Small interfering RNA-mediated knockdown of beta-arrestin-1 inhibits TNF{alpha}-induced tyrosine phosphorylation of G{alpha}q/11 by interruption of Src kinase activation. TNF{alpha} stimulates lipolysis in 3T3-L1 adipocytes, and beta-arrestin-1 knockdown blocks the effects of TNF{alpha} to stimulate ERK activation and glycerol release. TNF{alpha} also led to activation of JNK with increased expression of the proinflammatory gene, monocyte chemoattractant protein-1 and matrix metalloproteinase 3, and beta-arrestin-1 knockdown inhibited both of these effects. Taken together these results reveal novel elements of TNF{alpha} action; 1) the trimeric G-protein component G{alpha}q/11 and the adapter protein beta-arrestin-1 can function as signaling molecules in the TNF{alpha} action cascade; 2) beta-arrestin-1 can couple TNF{alpha} stimulation to ERK activation and lipolysis; 3) beta-arrestin-1 and G{alpha}q/11 can mediate TNF{alpha}-induced phosphatidylinositol 3-kinase activation and inflammatory gene expression.


Received for publication, July 17, 2007

* This work was supported by National Institutes of Health Research Grant DK 33651, University of California Discovery Program Project bio03-10383 (BioStar), and United States and Israel Binational Scientific Foundation Grant 2003238. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 To whom correspondence should be addressed: University of California, San Diego, Dept. of Medicine (0673), 9500 Gilman Dr., La Jolla, CA 92093. Tel.: 858-534-6651; Fax: 858-534-6653; E-mail: jolefsky{at}ucsd.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Lymperopoulos, G. Rengo, C. Zincarelli, J. Kim, S. Soltys, and W. J. Koch
An adrenal {beta}-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo
PNAS, April 7, 2009; 106(14): 5825 - 5830.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Sonoda, T. Imamura, T. Yoshizaki, J. L. Babendure, J.-C. Lu, and J. M. Olefsky
{beta}-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic {beta} cells
PNAS, May 6, 2008; 105(18): 6614 - 6619.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement